Viewing Study NCT00162734


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-03-08 @ 4:44 AM
Study NCT ID: NCT00162734
Status: COMPLETED
Last Update Posted: 2012-06-22
First Post: 2005-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
Sponsor: Bausch Health Americas, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Hepatitis C View
None Liver View
None Pegylated View
None Interferon View
None Alpha View
None Ribavirin View
None Combination View
None Nonresponder View
None HCV View
None Infergen View
None SVR View